Search results
Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding
Motley Fool· 2 years agoShares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4%...
Is Moderna About to Face the Same Challenge as Other Biotechs?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) has brought in billions thanks to its coronavirus vaccine. Now, though, the...
Does This FDA Panel Vote Make Moderna a Buy?
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) has been a leader in the coronavirus vaccine race from the start. It was the first to begin clinical trials of a vaccine...
3 Things About Moderna That Smart Investors Know
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) helped some investors make a fortune over the past few years. The stock has climbed more than 400% since March 2020 -- that's when...
Can Moderna Achieve Its Most Ambitious Goal Yet?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) and ambition seem to go hand and hand. The company doesn't fear taking on challenges, as it demonstrated during the earliest days...
COVID Vaccine Sales Are Declining. But Here's How They're Still Driving Growth at Moderna.
Motley Fool· 8 months agoRight now, Moderna (NASDAQ: MRNA) generates pretty much all of its revenue from one product: its...
Better Buy: Pfizer vs. Moderna
Motley Fool· 1 year agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have one big thing in common. Both companies have dominated the coronavirus vaccine market -- and aim to...
3 Things You Need to Know About Moderna's Post-Pandemic Revenue
Motley Fool· 2 years agoDuring the pandemic, Moderna's (NASDAQ: MRNA) billion-dollar revenue has been pretty much a sure...
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?
Motley Fool via Yahoo Finance· 4 months agoIt's the beginning of the year, when many investors sell some winners and rotate into last year's...
Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now
Motley Fool· 7 months agoYou don't need a pile of cash to invest in some of today's beaten-down growth stocks. Moderna stock...